NP Life Sciences Health Industry Group annual operating margin
2019
2020
2021
2022
2023
NP Life Sciences Health Industry Group's operating margin was −0.42% for fiscal 2023.
View full NP Life Sciences Health Industry Group company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-12-31 | −0.42% | +18.07 pp |
| 2022 | 2022-12-31 | −18.48% | +169.22 pp |
| 2021 | 2021-12-31 | −187.70% | +686.24 pp |
| 2020 | 2020-12-31 | −873.94% | −620.78 pp |
| 2019 | 2019-12-31 | −253.16% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2023 | 2023-12-31 | −358.37% | −345.10 pp |
| Q3 2023 | 2023-09-30 | −213.79% | −220.98 pp |
| Q2 2023 | 2023-06-30 | 66.66% | +267.55 pp |
| Q1 2023 | 2023-03-31 | 4.08% | +142.75 pp |
| Q3 2022 | 2022-09-30 | −13.27% | +6.98 pp |
| Q2 2022 | 2022-06-30 | 7.19% | +155.70 pp |
| Q1 2020 | 2020-03-31 | −200.89% | — |
| Q3 2019 | 2019-09-30 | −138.67% | — |
| Q2 2019 | 2019-06-30 | −20.25% | — |
| Q1 2019 | 2019-03-31 | −148.51% | — |
Across the available reported history, NP Life Sciences Health Industry Group's operating margin increased from −18.48% to −0.42%, a change of +18.07 percentage points. The latest reported quarter, Q4 2023, shows −358.37%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review NP Life Sciences Health Industry Group filings at SEC.gov ↗